These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 14617225
1. Pharmacokinetics and anti-hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-d- arabinitol, in glucagon-challenged rats and dogs and in diabetic ob/ob mice. Mackay P, Ynddal L, Andersen JV, McCormack JG. Diabetes Obes Metab; 2003 Nov; 5(6):397-407. PubMed ID: 14617225 [Abstract] [Full Text] [Related]
2. Kinetic and functional characterization of 1,4-dideoxy-1, 4-imino-d-arabinitol: a potent inhibitor of glycogen phosphorylase with anti-hyperglyceamic effect in ob/ob mice. Fosgerau K, Westergaard N, Quistorff B, Grunnet N, Kristiansen M, Lundgren K. Arch Biochem Biophys; 2000 Aug 15; 380(2):274-84. PubMed ID: 10933882 [Abstract] [Full Text] [Related]
3. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors. Andersen B, Westergaard N. Biochem J; 2002 Oct 15; 367(Pt 2):443-50. PubMed ID: 12099891 [Abstract] [Full Text] [Related]
5. Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino-D-arabinitol. Andersen B, Rassov A, Westergaard N, Lundgren K. Biochem J; 1999 Sep 15; 342 Pt 3(Pt 3):545-50. PubMed ID: 10477265 [Abstract] [Full Text] [Related]
7. Glucagon challenge in the rat: a robust method for the in vivo assessment of Glycogen phosphorlyase inhibitor efficacy. Loxham SJ, Teague J, Poucher SM, De Schoolmeester J, Turnbull AV, Carey F. J Pharmacol Toxicol Methods; 2007 Sep 15; 55(1):71-7. PubMed ID: 16713718 [Abstract] [Full Text] [Related]
11. Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes. Latsis T, Andersen B, Agius L. Biochem J; 2002 Nov 15; 368(Pt 1):309-16. PubMed ID: 12186629 [Abstract] [Full Text] [Related]
12. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors. Gregus Z, Németi B. Toxicol Sci; 2007 Nov 15; 100(1):44-53. PubMed ID: 17693424 [Abstract] [Full Text] [Related]
19. An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia. Poucher SM, Freeman S, Loxham SJ, Convey G, Bartlett JB, De Schoolmeester J, Teague J, Walker M, Turnbull AV, Charles AD, Carey F, Berg S. Br J Pharmacol; 2007 Dec 15; 152(8):1239-47. PubMed ID: 17934512 [Abstract] [Full Text] [Related]
20. FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. II. Anti-hyperglycemic effects in diabetic animal models. Furukawa S, Murakami K, Nishikawa M, Nakayama O, Hino M. J Antibiot (Tokyo); 2005 Aug 15; 58(8):503-6. PubMed ID: 16266121 [Abstract] [Full Text] [Related] Page: [Next] [New Search]